CN Patent

CN119968203A — 长效配制品

Assigned to Janssen Pharmaceutica NV · Expires 2025-05-09 · 1y expired

What this patent protects

本发明涉及用于经肌内或皮下注射施用的药物组合物，该药物组合物包含悬浮在药学上可接受的水性载体中的抗‑TB化合物贝达喹啉的微米颗粒，还涉及此类药物组合物在治疗和预防病原性分枝杆菌感染中的用途。

USPTO Abstract

本发明涉及用于经肌内或皮下注射施用的药物组合物，该药物组合物包含悬浮在药学上可接受的水性载体中的抗‑TB化合物贝达喹啉的微米颗粒，还涉及此类药物组合物在治疗和预防病原性分枝杆菌感染中的用途。

Drugs covered by this patent

Patent Metadata

Patent number
CN119968203A
Jurisdiction
CN
Classification
—
Expires
2025-05-09
Drug substance claim
No
Drug product claim
No
Assignee
Janssen Pharmaceutica NV
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.